UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ustekinumab as a therapeutic option for Takayasu arteritis: from genetic findings to clinical application

Scandinavian journal of rheumatology, 2016-01, Vol.45 (1), p.80-82

2016

Volltextzugriff (PDF)

Type I interferon induces CX3CL1 (fractalkine) and CCL5 (RANTES) production in human pulmonary vascular endothelial cells

Clinical and experimental immunology, 2012-10, Vol.170 (1), p.94-100

2012

Volltextzugriff (PDF)

POS0336 PATTERNS OF LARGE-VESSEL LESIONS AND POOR TREATMENT OUTCOMES IN PATIENTS WITH LARGE-VESSEL GIANT CELL ARTERITIS

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.395-396

2021

Volltextzugriff (PDF)

SAT0422 Indirect pathogenic roles of cerebrospinal fluid anti-u1rnp antibodies in the presence of anti-nr2 antibodies in patients with neuropsychiatric systemic lupus erythematosus

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1071

2018

Volltextzugriff (PDF)

FRI0331 Trough concentration of mycophenolic acid correlates with renal function and serum albumin level in japanese patients with sle

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.702

2018

Volltextzugriff (PDF)

AB0636 Ustekinumab as a Therapeutic Option for Takayasu Arteritis –from Genetic Findings to Clinical Application

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1111-1112

2015

Volltextzugriff (PDF)

OP0056 Association of IL-12P40 and IL-12P70 with Pathophysiology of Takayasu Arteritis

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.75-76

2016

Volltextzugriff (PDF)

FRI0511 Detection of Anti-Th/To Antibodies in Patients with Various Rheumatic Diseases and their Clinical Features

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.572-572

2014

Volltextzugriff (PDF)

FRI0143 Type I Interferon Plays A Key Role in Immunogenicity and Lupus-Like Autoimmunity in Patients with Rheumatoid Arthritis Treated by Infliximab

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.473-474

2015

Volltextzugriff (PDF)

SAT0594 Will Anti-Cyclic Citrullinated Peptide Antibody-Positive Connective Tissue Disease Patients Develop Rheumatoid Arthritis? Association with HLA-DRB1 Shared Epitope

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.876-877

2015

Volltextzugriff (PDF)

FRI0288 Immunogenicity is Associated with Lupus-Like Autoimmunity in Rheumatoid Arthritis Patients Treated with Infliximab

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.489-489

2014

Volltextzugriff (PDF)

SAT0223 The Onsets of Myositis with Myositis-Specific Autoantibodies (MSAS) are Associated With The Seasons

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A656-A656

2013

Volltextzugriff (PDF)

AB0506 Longitudinal change of the titer of anti-mda5 antibody and association with prognosis in dermatomyositis with interstitial pneumonia

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A943-A943

2013

Volltextzugriff (PDF)

THU0194 Association between autoantibodies and soluble factors in cerebrospinal fluids from patients with neuropsychiatric systemic lupus erythematosus

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.221-221

2013

Volltextzugriff (PDF)

SAT0069 A Clinical, Pathological and Genetic Characterization of Methotrexate-Associated Lymphoproliferative Disorders

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A603-A603

2013

Volltextzugriff (PDF)

AB1161 DECREASED ADAMTS13 ACTIVITY IN SCLERODERMA RENAL CRISIS

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.1914-1914

2024

Volltextzugriff (PDF)

POS0323 GUT COMMENSAL TRANSLOCATION AND MOLECULAR MIMICRY FOR AUTOANTIBODY PRODUCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.263-264

2024

Volltextzugriff (PDF)

OP0106 ROLES OF JAK-STAT SIGNALING AND GM-CSF FOR THE DEVELOPMENT OF OSTEITIS AND BONE MICROSTRUCTURE CHANGES IN RHEUMATOID ARTHRITIS

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.32-32

2024

Volltextzugriff (PDF)

POS0354 IDENTIFICATION OF SOMATIC MUTATIONS IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.427-427

2023

Volltextzugriff (PDF)

THU0023 DETAILED PROFILE OF CO-OCCURRENCE OF RELAPSING POLYCHONDRITIS AND AUTOIMMUNE THYROID DISEASE

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.224-225

2020

Volltextzugriff (PDF)

AB1050 ANALYSIS OF FACTORS INFLUENCING THE NUMBER OF CHILDREN OF FEMALE SLE PATIENTS BY PATIENT’S QUESTIONNAIRE

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.1848-1849

2024

Volltextzugriff (PDF)

SAT0349 CTLA4-IG DECREASES TH17 CELL LEVELS BUT MAINTAINS ILC3S WITH AN INCREASE IN THE ILC3/ILC1 RATIO IN THE GUT OF SKG MICE AS A MODEL OF SPONDYLOARTHRITIS

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.1120-1121

2020

Volltextzugriff (PDF)

POS0350 VALIDATION OF THE DIAGNOSTIC CRITERIA FOR IgG4-RELATED PERIAORTITIS/PERIARTERITIS AND RETROPERITONEAL FIBROSIS (IgG4-PA/RPF) 2018, AND PROPOSAL OF A REVISED 2023 VERSION FOR IgG4-RELATED CARDIOVASCULAR/RETROPERITONEAL DISEASE: A NATIONWIDE MULTICENTER STUDY

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.413-414

2024

Volltextzugriff (PDF)

AB0470 THE ASSOCIATIONS OF ANTI-DNA ANTIBODIES WITH DISEASE ACTIVITY INDICES AND PATIENT REPORT OUTCOME PARAMETERS OF SLE IN KYOTO LUPUS COHORT

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.1362-1362

2022

Volltextzugriff (PDF)

AB0046 OMEGA-3 EPOXIDES AMELIORATE MURINE INFLAMMATORY ARTHRITIS

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.1202-1202

2023

Volltextzugriff (PDF)

1 – 25 von 178

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(106)

Publikationsform

Sprache

Englisch
(173)
Japanisch
(5)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Ustekinumab as a therapeutic option for Takayasu arteritis: from genetic findings to clinical application

Type I interferon induces CX3CL1 (fractalkine) and CCL5 (RANTES) production in human pulmonary vascular endothelial cells

POS0336 PATTERNS OF LARGE-VESSEL LESIONS AND POOR TREATMENT OUTCOMES IN PATIENTS WITH LARGE-VESSEL GIANT CELL ARTERITIS

SAT0422 Indirect pathogenic roles of cerebrospinal fluid anti-u1rnp antibodies in the presence of anti-nr2 antibodies in patients with neuropsychiatric systemic lupus erythematosus

FRI0331 Trough concentration of mycophenolic acid correlates with renal function and serum albumin level in japanese patients with sle

AB0636 Ustekinumab as a Therapeutic Option for Takayasu Arteritis –from Genetic Findings to Clinical Application

OP0056 Association of IL-12P40 and IL-12P70 with Pathophysiology of Takayasu Arteritis

FRI0511 Detection of Anti-Th/To Antibodies in Patients with Various Rheumatic Diseases and their Clinical Features

FRI0143 Type I Interferon Plays A Key Role in Immunogenicity and Lupus-Like Autoimmunity in Patients with Rheumatoid Arthritis Treated by Infliximab

SAT0594 Will Anti-Cyclic Citrullinated Peptide Antibody-Positive Connective Tissue Disease Patients Develop Rheumatoid Arthritis? Association with HLA-DRB1 Shared Epitope

FRI0288 Immunogenicity is Associated with Lupus-Like Autoimmunity in Rheumatoid Arthritis Patients Treated with Infliximab

SAT0223 The Onsets of Myositis with Myositis-Specific Autoantibodies (MSAS) are Associated With The Seasons

AB0506 Longitudinal change of the titer of anti-mda5 antibody and association with prognosis in dermatomyositis with interstitial pneumonia

THU0194 Association between autoantibodies and soluble factors in cerebrospinal fluids from patients with neuropsychiatric systemic lupus erythematosus

SAT0069 A Clinical, Pathological and Genetic Characterization of Methotrexate-Associated Lymphoproliferative Disorders

AB1161 DECREASED ADAMTS13 ACTIVITY IN SCLERODERMA RENAL CRISIS

POS0323 GUT COMMENSAL TRANSLOCATION AND MOLECULAR MIMICRY FOR AUTOANTIBODY PRODUCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS

OP0106 ROLES OF JAK-STAT SIGNALING AND GM-CSF FOR THE DEVELOPMENT OF OSTEITIS AND BONE MICROSTRUCTURE CHANGES IN RHEUMATOID ARTHRITIS

POS0354 IDENTIFICATION OF SOMATIC MUTATIONS IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS

THU0023 DETAILED PROFILE OF CO-OCCURRENCE OF RELAPSING POLYCHONDRITIS AND AUTOIMMUNE THYROID DISEASE

AB1050 ANALYSIS OF FACTORS INFLUENCING THE NUMBER OF CHILDREN OF FEMALE SLE PATIENTS BY PATIENT’S QUESTIONNAIRE

SAT0349 CTLA4-IG DECREASES TH17 CELL LEVELS BUT MAINTAINS ILC3S WITH AN INCREASE IN THE ILC3/ILC1 RATIO IN THE GUT OF SKG MICE AS A MODEL OF SPONDYLOARTHRITIS

POS0350 VALIDATION OF THE DIAGNOSTIC CRITERIA FOR IgG4-RELATED PERIAORTITIS/PERIARTERITIS AND RETROPERITONEAL FIBROSIS (IgG4-PA/RPF) 2018, AND PROPOSAL OF A REVISED 2023 VERSION FOR IgG4-RELATED CARDIOVASCULAR/RETROPERITONEAL DISEASE: A NATIONWIDE MULTICENTER STUDY

AB0470 THE ASSOCIATIONS OF ANTI-DNA ANTIBODIES WITH DISEASE ACTIVITY INDICES AND PATIENT REPORT OUTCOME PARAMETERS OF SLE IN KYOTO LUPUS COHORT

AB0046 OMEGA-3 EPOXIDES AMELIORATE MURINE INFLAMMATORY ARTHRITIS

Aktive Filter

Suchergebnisse filtern